rs11135176

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001375350.1(GABRG2):​c.-44C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0971 in 1,598,584 control chromosomes in the GnomAD database, including 10,705 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.084 ( 884 hom., cov: 32)
Exomes 𝑓: 0.098 ( 9821 hom. )

Consequence

GABRG2
NM_001375350.1 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.284

Publications

26 publications found
Variant links:
Genes affected
GABRG2 (HGNC:4087): (gamma-aminobutyric acid type A receptor subunit gamma2) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammlian brain, where it acts at GABA-A receptors, which are ligand-gated chloride channels. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene have been associated with epilepsy and febrile seizures. Multiple transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
GABRG2 Gene-Disease associations (from GenCC):
  • epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 74
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 8
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • generalized epilepsy with febrile seizures plus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 5-162095550-C-T is Benign according to our data. Variant chr5-162095550-C-T is described in ClinVar as Benign. ClinVar VariationId is 129127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001375350.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRG2
NM_198904.4
MANE Select
c.315C>Tp.Asn105Asn
synonymous
Exon 3 of 10NP_944494.1
GABRG2
NM_001375350.1
c.-44C>T
5_prime_UTR_premature_start_codon_gain
Exon 3 of 10NP_001362279.1
GABRG2
NM_001375348.1
c.-44C>T
5_prime_UTR_premature_start_codon_gain
Exon 3 of 9NP_001362277.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRG2
ENST00000639213.2
TSL:1 MANE Select
c.315C>Tp.Asn105Asn
synonymous
Exon 3 of 10ENSP00000491909.2
GABRG2
ENST00000414552.6
TSL:1
c.315C>Tp.Asn105Asn
synonymous
Exon 3 of 11ENSP00000410732.2
GABRG2
ENST00000639111.2
TSL:1
c.315C>Tp.Asn105Asn
synonymous
Exon 3 of 9ENSP00000492125.2

Frequencies

GnomAD3 genomes
AF:
0.0841
AC:
12774
AN:
151980
Hom.:
872
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0196
Gnomad AMI
AF:
0.0691
Gnomad AMR
AF:
0.199
Gnomad ASJ
AF:
0.0369
Gnomad EAS
AF:
0.227
Gnomad SAS
AF:
0.205
Gnomad FIN
AF:
0.0808
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0817
Gnomad OTH
AF:
0.0699
GnomAD2 exomes
AF:
0.130
AC:
32325
AN:
248550
AF XY:
0.125
show subpopulations
Gnomad AFR exome
AF:
0.0176
Gnomad AMR exome
AF:
0.324
Gnomad ASJ exome
AF:
0.0382
Gnomad EAS exome
AF:
0.213
Gnomad FIN exome
AF:
0.0806
Gnomad NFE exome
AF:
0.0776
Gnomad OTH exome
AF:
0.105
GnomAD4 exome
AF:
0.0985
AC:
142433
AN:
1446486
Hom.:
9821
Cov.:
28
AF XY:
0.100
AC XY:
72102
AN XY:
720464
show subpopulations
African (AFR)
AF:
0.0151
AC:
500
AN:
33212
American (AMR)
AF:
0.307
AC:
13600
AN:
44330
Ashkenazi Jewish (ASJ)
AF:
0.0405
AC:
1053
AN:
25978
East Asian (EAS)
AF:
0.256
AC:
10063
AN:
39356
South Asian (SAS)
AF:
0.187
AC:
16020
AN:
85714
European-Finnish (FIN)
AF:
0.0835
AC:
4443
AN:
53232
Middle Eastern (MID)
AF:
0.0386
AC:
222
AN:
5748
European-Non Finnish (NFE)
AF:
0.0827
AC:
90902
AN:
1099164
Other (OTH)
AF:
0.0942
AC:
5630
AN:
59752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
5607
11215
16822
22430
28037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3620
7240
10860
14480
18100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0841
AC:
12795
AN:
152098
Hom.:
884
Cov.:
32
AF XY:
0.0888
AC XY:
6598
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.0196
AC:
813
AN:
41530
American (AMR)
AF:
0.201
AC:
3060
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.0369
AC:
128
AN:
3470
East Asian (EAS)
AF:
0.227
AC:
1172
AN:
5168
South Asian (SAS)
AF:
0.204
AC:
983
AN:
4816
European-Finnish (FIN)
AF:
0.0808
AC:
854
AN:
10572
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0817
AC:
5556
AN:
67980
Other (OTH)
AF:
0.0720
AC:
152
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
568
1136
1705
2273
2841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0778
Hom.:
1354
Bravo
AF:
0.0893
Asia WGS
AF:
0.227
AC:
789
AN:
3476
EpiCase
AF:
0.0796
EpiControl
AF:
0.0680

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2 (1)
-
-
1
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2;C1969810:Febrile seizures, familial, 8 (1)
-
-
1
Febrile seizures, familial, 8 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
0.43
DANN
Benign
0.64
PhyloP100
-0.28
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11135176; hg19: chr5-161522556; COSMIC: COSV62718265; COSMIC: COSV62718265; API